ScholarIQanswers from OpenAlex
Radboud University Nijmegen
InstitutionResearch output, impact & collaborations
Radboud University Nijmegen is a institution indexed in ScholarIQ from OpenAlex.
What is known about Radboud University Nijmegen?
ScholarIQrecord summary
Radboud University Nijmegen is a research organisation in Nijmegen, NL. OpenAlex records 208,541 works and 25,256,604 citations for it. 39,831 researchers list it as their most recent affiliation.
How many works does Radboud University Nijmegen have?
ScholarIQindexed works
Radboud University Nijmegen has 208,541 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Radboud University Nijmegen have?
ScholarIQcitation count
Radboud University Nijmegen has 25,256,604 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Radboud University Nijmegen?
ScholarIQresearcher count
Radboud University Nijmegen has 39,831 researchers in the ScholarIQ index.
What is the average h-index at Radboud University Nijmegen?
ScholarIQavg h-index
Radboud University Nijmegen has an average h-index of 73.7 in OpenAlex.
What is the ROR of Radboud University Nijmegen?
ScholarIQror
The ROR for Radboud University Nijmegen is on the source record.
What is the OpenAlex record for Radboud University Nijmegen?
ScholarIQopenalex
The OpenAlex for Radboud University Nijmegen is on the source record.
What is the Wikidata of Radboud University Nijmegen?
ScholarIQwikidata
The Wikidata for Radboud University Nijmegen is on the source record.
Who are the most-cited researchers behind Radboud University Nijmegen?
ScholarIQtop researchers by citations
What are the most-cited papers on Radboud University Nijmegen?
ScholarIQmost cited works
Signatures of mutational processes in human cancer
Australian Pancreatic Cancer Genome Initiative, Ludmil B. Alexandrov, ICGC PedBrain, Serena Nik‐Zainal, David C. Wedge, Samuel Aparício, Sam Behjati, Andrew V. Biankin, Graham R. Bignell, Niccolò Bolli, Åke Borg, Anne‐Lise Børresen‐Dale, Sandrine Boyault, Birgit Burkhardt, Adam P. Butler, Carlos Caldas, Helen Davies, Christine Desmedt, Roland Eils, Jórunn E. Eyfjörd, John A. Foekens, Mel Greaves, Fumie Hosoda, Barbara Hutter, Tomislav Ilicic, Sandrine Imbeaud, Marcin Imieliński, Natalie Jäger, David Jones, David R. Jones, Stian Knappskog, Marcel Kool, Sunil R. Lakhani, Carlos López-Otı́n, Sancha Martin, Nikhil C. Munshi, Hiromi Nakamura, Paul A. Northcott, Marina Pajic, Elli Papaemmanuil, Angelo Paradiso, John V. Pearson, Xosé S. Puente, Keiran Raine, Manasa Ramakrishna, Andrea L. Richardson, Julia Richter, Philip Rosenstiel, Matthias Schlesner, Ton N. Schumacher, Paul N. Span, Jon W. Teague, Yasushi Totoki, Andrew Tutt, Rafael Valdés‐Mas, Marit M. van Buuren, Laura van ‘t Veer, Anne Vincent‐Salomon, Nicola Waddell, Lucy Yates, Jessica Zucman‐Rossi, P. Andrew Futreal, Ultan McDermott, Peter Lichter, Matthew Meyerson, Sean M. Grimmond, Reiner Siebert, Elı́as Campo, Tatsuhiro Shibata, Stefan M. Pfister, Peter J. Campbell, Michael R. Stratton
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger, John H. Alexander, John J.V. McMurray, Renato D. Lópes, Elaine M. Hylek, Michael G. Hanna, Hussein R. Al‐Khalidi, Jack Ansell, Dan Atar, Álvaro Avezum, M. Cecilia Bahit, Rafael Díaz, J. Donald Easton, Justin A. Ezekowitz, Greg Flaker, David García, Margarida Geraldes, Bernard J. Gersh, Golitsyn Sp, Shinya Goto, Antonio G. Hermosillo, Stefan H. Hohnloser, John D. Horowitz, Puneet Mohan, Petr Janský, Basil S. Lewis, José López‐Sendón, Prem Pais, Alexander Parkhomenko, Freek W.A. Verheugt, Jun Zhu, Lars Wallentin
MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C. Warren Olanow, Wolfgang H. Oertel, José Á. Obeso, Kenneth Marek, Irene Litvan, Anthony E. Lang, Glenda M. Halliday, Christopher G. Goetz, Thomas Gasser, Bruno Dubois, Piu Chan, Bastiaan R. Bloem, Charles H. Adler, Günther Deuschl
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli, Elena Carrara, Alessia Savoldi, Stephan Harbarth, Marc Mendelson, Dominique L. Monnet, Céline Pulcini, Gunnar Kahlmeter, Jan Kluytmans, Yehuda Carmeli, Marc Ouellette, Kevin Outterson, Jean B. Patel, Marco Cavaleri, Edward Cox, Chris R Houchens, M. Lindsay Grayson, Paul Hansen, Nalini Singh, Ursula Theuretzbacher, Nicola Magrini, Aaron O. Aboderin, Seif Al-Abri, Nordiah Awang Jalil, Nur Benzonana, Sanjay Bhattacharya, Adrian Brink, Francesco Burkert, Otto Cars, Giuseppe Cornaglia, Oliver J. Dyar, Alex W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy Jinks, Souha S. Kanj, Lawrence D. Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman S. Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Gabriel Levy-Hara, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, Nguyễn Văn Kính, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet
How much of the research on Radboud University Nijmegen is open access?
ScholarIQopen access share
92%OPEN ACCESS